HomeInsightsPE

Ipca Laboratories Ltd PE Ratio

Ipca Laboratories Ltd PE Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Ipca Laboratories Ltd

NSE: IPCALAB

PE

60.1

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Ipca Laboratories Ltd is 60.1 as of 23 Nov 09:56 AM .
  • The P/E Ratio of Ipca Laboratories Ltd changed from 27.9 on March 2019 to 57.4 on March 2024 . This represents a CAGR of 12.78% over 6 years.
  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1590 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Ipca Laboratories Ltd

No data available

Company Fundamentals for Ipca Laboratories Ltd

No data available

Image

Ipca Laboratories Ltd

NSE: IPCALAB

Share Price

₹ 1590.55

17.35 (1.10%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Ipca Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ipca Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241590.55
21 Nov 20241573.2
19 Nov 20241573.1
18 Nov 20241566.85
14 Nov 20241536.95
13 Nov 20241508.15
12 Nov 20241557.15
11 Nov 20241531.5
08 Nov 20241556.65
07 Nov 20241557.55

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ipca Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Ipca Laboratories Ltd6040,352
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Ipca Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ipca Laboratories Ltd

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories Ltd soars 2.3%, rises for third straight session

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs ...

Read more

2024-08-21 00:00:00

News

Ipca Laboratories consolidated net profit rises 18.07% in the June 2024 quarter

Net profit of Ipca Laboratories rose 18.07% to Rs 192.24 crore in the quarter ended June 2...

Read more

2024-08-13 00:00:00

News

Ipca Laboratories Ltd gains for fifth session

Ipca Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at...

Read more

2024-08-12 00:00:00

News

Ipca Laboratories Ltd soars 2.1%

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at...

Read more

2024-08-08 00:00:00

News

Ipca Laboratories Ltd up for third consecutive session

Ipca Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs...

Read more

2024-09-05 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ipca Laboratories Ltd

What is the current PE Ratio of Ipca Laboratories Ltd?

The Current PE Ratio of Ipca Laboratories Ltd is 60.09 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Ipca Laboratories Ltd last year?

The PE Ratio of Ipca Laboratories Ltd was 43.61 last year, now the PE ratio is 60.09, showing a year-on-year growth of 37.8%.

What does the PE Ratio of Ipca Laboratories Ltd indicate about its stock?

The PE Ratio of Ipca Laboratories Ltd is 60.09. This ratio indicates that investors are willing to pay 60.09 times the earnings per share for each share of Ipca Laboratories Ltd.

What is the PE Ratio Growth of Ipca Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ipca Laboratories Ltd grew by 37.8% whereas, the EPS ratio grew by 19.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*